Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
HRMY
#1797
Harmony Biosciences Holdings, Inc. Common Stock
28.540
0
+0.25%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
+0.25%
Changement Mensuel
-24.24%
Evolution sur 6 mois
-7.64%
Changement Annuel
-7.64%
Clôture Précédente
28.470
0
Open
28.540
0
Bid
Ask
Low
28.540
0
High
28.540
0
Volume
110
Marchés
Actions des Marchés US
Soins de Santé
HRMY
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
Nouvelles
BEAM's Q4 Loss Narrower Than Expected, Revenues Rise Y/Y
IOVA Beats on Q4 Earnings & Sales, Stock Soars on Pipeline Progress
RXRX Q4 Loss Narrower Than Expected, Revenues Increase Y/Y, Stock Up
Corcept's Q4 Earnings and Revenues Fall Short of Estimates
Repligen's Q4 Earnings Beat Estimates, Revenues Surge Y/Y
Apellis Q4 Loss Wider Than Expected, Revenues Decline Y/Y
Früherer Generika-Start für Wakix: UBS senkt Kursziel für Harmony Biosciences
UBS cuts Harmony Biosciences stock price target on earlier Wakix generic entry
Truist bestätigt "Halten"-Rating für Harmony Biosciences mit Kursziel von 25 US-Dollar
Truist reiterates Hold on Harmony Biosciences stock, sets $25 target
AXSM Q4 Loss Wider Than Expected, Revenues Surge Y/Y on Auvelity Sales
BMRN Beats on Q4 Earnings, to Withdraw Roctavian From Market